학술논문
Efficacy and safety of a universal influenza A vaccine (MVA-NP+M1) in adults when given after seasonal quadrivalent influenza vaccine immunisation (FLU009): a phase 2b, randomised, double-blind trial
Document Type
Article
Author
Source
In The Lancet Infectious Diseases June 2022 22(6):857-866
Subject
Language
ISSN
1473-3099